167 related articles for article (PubMed ID: 7238955)
21. [Cardiac impairments induced by adoptive transfer of lymphocytes from the experimental cardiomyopathy in mice].
Yuan J; Liao YH; Wang ZH; Zhang JH; Tian Y; Dong JH; Wang JP
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):892-6. PubMed ID: 16029527
[TBL] [Abstract][Full Text] [Related]
22. [Combined surgical and specific passive xenogenic immunotherapy in UVT tumor-bearing inbred XVII/Bln mice].
Winzer KJ
Z Exp Chir; 1981; 14(2):90-7. PubMed ID: 7257469
[TBL] [Abstract][Full Text] [Related]
23. Study on the immunological reactivity of mice with solid Ehrlich adenocarcinoma.
Botev B; Marholev L
C R Acad Bulg Sci; 1970; 23(4):451-3. PubMed ID: 4919477
[No Abstract] [Full Text] [Related]
24. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
Baral R; Chattopadhyay U
Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
[TBL] [Abstract][Full Text] [Related]
25. Studies on the cell cycle of Ehrlich carcinoma cells transplanted into allogeneic and xenogeneic hosts.
Janik P
Arch Immunol Ther Exp (Warsz); 1969; 17(5):590-6. PubMed ID: 5370177
[No Abstract] [Full Text] [Related]
26. Study on immunological reactivity of mice treated with antigen from ascitic form of Ehrlich carcinoma.
Botev B; Marholev L; Zaharieva E; Golemanova E
C R Acad Bulg Sci; 1970; 23(4):455-6. PubMed ID: 4919478
[No Abstract] [Full Text] [Related]
27. [Migration capacity of tumor cells treated with immune sera].
Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
Biull Eksp Biol Med; 1977 Dec; 84(12):712-4. PubMed ID: 597608
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte-antibody interactions in immunological enhancement.
Takasugi M; Hildemann WH
Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
[No Abstract] [Full Text] [Related]
29. Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-gamma and restrains serum sialic acid and gamma glutamyl transpeptidase production in tumor - bearing animals.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2007; 6(4):285-95. PubMed ID: 18038762
[TBL] [Abstract][Full Text] [Related]
30. Effector cells in avian spontaneous and antibody-dependent cell-mediated cytotoxicity.
Fleischer B
J Immunol; 1980 Sep; 125(3):1161-6. PubMed ID: 7410832
[TBL] [Abstract][Full Text] [Related]
31. The cell populations mediating natural killing-(NK) and antibody-dependent cell-mediated cytotoxicity are only partially identical.
Bardos P; Altman J; Guillou PJ; Carnaud C
Clin Exp Immunol; 1981 Mar; 43(3):534-9. PubMed ID: 7285391
[TBL] [Abstract][Full Text] [Related]
32. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
[TBL] [Abstract][Full Text] [Related]
33. Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.
Mauel J; Rudolf H; Chapuis B; Brunner KT
Immunology; 1970 Apr; 18(4):517-35. PubMed ID: 5421033
[TBL] [Abstract][Full Text] [Related]
34. MLR and skin graft studies in xenogeneic iso-, allo-, and xeno-combinations using HLA-DP and -DQ transgenic mice.
Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
Transplant Proc; 1994 Apr; 26(2):967-8. PubMed ID: 8171718
[No Abstract] [Full Text] [Related]
35. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
Novikov DK
Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
[No Abstract] [Full Text] [Related]
37. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
[No Abstract] [Full Text] [Related]
38. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
Saha S; Mondal S
Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses.
Ji YH; Weiss L; Zeira M; Abdul-Hai A; Reich S; Schuger L; Slavin S
Bone Marrow Transplant; 2003 Sep; 32(5):495-504. PubMed ID: 12942096
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of cell-mediated cytotoxicity in mice rejecting xenogeneic human lymphoblastoid cells.
Carnaud C; Altman J; Errasti P; Van der Gaag R
Scand J Immunol; 1980; 11(5):503-10. PubMed ID: 6966822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
